Deutsche Bank
ALXO icon

Deutsche Bank’s ALX Oncology ALXO Stock Holding History

Deutsche Bank’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-101,113
Closed -$62.7K – 3609
2025
Q1 		$62.7K Hold
101,113
– – ﹤0.01% 3332
2024
Q4 		$169K Buy
101,113
+84,830
+521% +$130K ﹤0.01% 3141
2024
Q3 		$29.6K Buy
16,283
+5,849
+56% +$21.7K ﹤0.01% 3434
2024
Q2 		$62.9K Sell
10,434
-1,054
-9% -$13K ﹤0.01% 3271
2024
Q1 		$128K Buy
11,488
+366
+3% +$5.14K ﹤0.01% 3050
2023
Q4 		$166K Buy
11,122
+333
+3% +$3.16K ﹤0.01% 2976
2023
Q3 		$51.8K Sell
10,789
-182,686
-94% -$991K ﹤0.01% 3404
2023
Q2 		$1.45M Sell
193,475
-153,314
-44% -$1M ﹤0.01% 1780
2023
Q1 		$1.57M Buy
346,789
+4,434
+1% +$33.6K ﹤0.01% 1825
2022
Q4 		$3.86M Buy
342,355
+142
+0% +$1.59K ﹤0.01% 1324
2022
Q3 		$3.27M Buy
342,213
+394
+0.1% +$4.59K ﹤0.01% 1388
2022
Q2 		$2.77M Sell
341,819
-1,844
-0.5% -$20.1K ﹤0.01% 1587
2022
Q1 		$5.81M Buy
343,663
+332,243
+2,909% +$5.67M ﹤0.01% 1337
2021
Q4 		$245K Sell
11,420
-4,203
-27% -$181K ﹤0.01% 3277
2021
Q3 		$1.15M Buy
15,623
+4,360
+39% +$291K ﹤0.01% 2520
2021
Q2 		$616K Sell
11,263
-345
-3% -$20.6K ﹤0.01% 3082
2021
Q1 		$855K Buy
11,608
+4,476
+63% +$352K ﹤0.01% 2758
2020
Q4 		$615K Buy
7,132
+2,024
+40% +$122K ﹤0.01% 2761
2020
Q3 		$193K Buy
+5,108
New +$201K ﹤0.01% 3234

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Deutsche Bank's ALXO Position: Q2 2025 in Review

Deutsche Bank sold out of ALX Oncology (ALXO) in Q2 2025, closing a stake of 101,113 shares — an estimated $62.7K sold.

Deutsche Bank first reported a position in ALXO in Q3 2020 and held it in 19 quarters. The position peaked at $5.81M in Q1 2022. 61 funds tracked by Wall St. Rank hold ALXO as of Q2 2025.

  • Deutsche Bank reported no remaining ALX Oncology position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 101,113 ALX Oncology shares in Q2 2025, an estimated $62.7K.
  • Deutsche Bank first reported a position in ALX Oncology in Q3 2020 and held it in 19 quarters.
  • Deutsche Bank's ALX Oncology position peaked at $5.81M in Q1 2022.
  • 61 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.